Mifomelatide

N/A

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameMifomelatide
Drug Alias NameTCMCB-07B07
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMelanocortin receptor 4 antagonistsMelanocortin receptor 3 antagonists
TargetsMelanocortin receptor 4Melanocortin receptor 3
Therapy Area/IndicationsCachexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEndevica Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKalohexis LLCEndevica Bio Inc
Inactive CompaniesN/A
Active IndicationsCachexia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A